Literature DB >> 10845618

Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP.

B A Berkowitz1, W Zhang.   

Abstract

PURPOSE: To test the hypothesis that after supplemental oxygen recovery (SOR) in the newborn rat model of retinopathy of prematurity (ROP) the preretinal neovascular (NV) incidence and severity are decreased and the panretinal oxygenation ability is improved.
METHODS: Newborn rats were first raised in either room air (controls) or variable oxygen (50%/10%) for 14 days. The experimental rats were recovered during the next 6 days (until day 20) in either room air (21% O2) or supplemental oxygen (28%). All groups were then exposed to room air for an additional 6 days (until day 26). On day 20, magnetic resonance imaging (MRI) was used to determine the panretinal oxygenation response (deltaPO2, mm Hg) to a carbogen (95% O2/5% CO2) inhalation challenge. On days 20 and 26, the retinas from a different subset of control, room air-recovered, or SOR-recovered animals were analyzed using ADPase stained or fluorescein-labeled dextran infused retinal flatmounts.
RESULTS: On day 20, the panretinal deltaPO2 of the room air-recovered group (125 +/- 5 mm Hg, mean +/- SEM, n = 12) was significantly (P < 0.05) lower than that of the control group (179 +/- 6 mm Hg, n = 11). The panretinal deltaPO2 value for the SOR group (87 +/- 5 mm Hg, n = 7) was significantly (P < 0.05) lower than both the room air-recovered group and the control group. The NV incidence and severity were significantly reduced (P < 0.05) in the SOR animals compared with the room air-recovered animals. In contrast, on day 26 (after 6 days in room air), the NV incidence was statistically (P < 0.05) greater in the animals that had been exposed to SOR compared with room air-recovered animals.
CONCLUSIONS: After 28% SOR, the expected decrease in NV incidence and severity occurred but with an unexpected decrease in panretinal oxygenation ability. The present data strongly support an association between subnormal panretinal oxygenation ability and increased NV risk in the newborn rat ROP model. MRI appears to be a powerful new approach for quantitatively and noninvasively measuring retinal oxygenation and may be applicable to study other ischemic or ischemia-related retinopathies in addition to ROP, such as diabetic retinopathy, sickle cell retinopathy, macular degeneration, and glaucoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845618

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis.

Authors:  Zhihong Yang; Haibo Wang; Yanchao Jiang; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2014-03-12       Impact factor: 4.307

Review 2.  Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Clin Perinatol       Date:  2014-09-23       Impact factor: 3.430

3.  Effect of bicarbonate on retinal vasculature and acidosis-induced retinopathy in the neonatal rat.

Authors:  John P Berdahl; David A Leske; Michael P Fautsch; William L Lanier; Jonathan M Holmes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-19       Impact factor: 3.117

4.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Authors:  Yuta Saito; Abhineet Uppal; Grace Byfield; Steven Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

Review 5.  Oxygen supply and consumption in the retina: implications for studies of retinopathy of prematurity.

Authors:  Stephen J Cringle; Dao-Yi Yu
Journal:  Doc Ophthalmol       Date:  2009-10-15       Impact factor: 2.379

Review 6.  The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.

Authors:  M Elizabeth Hartnett
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

Review 7.  Evidence for a critical role of panretinal pathophysiology in experimental ROP.

Authors:  Bruce A Berkowitz; Robin Roberts
Journal:  Doc Ophthalmol       Date:  2009-06-09       Impact factor: 2.379

Review 8.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

9.  Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity.

Authors:  Bruce A Berkowitz; David Bissig; Deborah Bergman; Emanuela Bercea; Vijaya K Kasturi; Robin Roberts
Journal:  Mol Vis       Date:  2011-09-27       Impact factor: 2.367

10.  Inner retinal oxygen metabolism in the 50/10 oxygen-induced retinopathy model.

Authors:  Brian T Soetikno; Ji Yi; Ronil Shah; Wenzhong Liu; Patryk Purta; Hao F Zhang; Amani A Fawzi
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.